It has been just revealed the fact that new research found the fact that an existing drug could be helping people with painful osteoarthritis. Check out the following reports about the matter below in order to learn all the available details.
New drug can help people with osteoarthritis
Here is what we learned so far. Osteoarthritis is a prevalent joint disease that frequently affects the hands. By the age of 85, one in two women and one in four men will face symptoms of hand osteoarthritis.
The disease causes pain and stiffness in the hands, which can significantly hinder a person’s ability to carry out daily activities such as dressing and eating, along with leisure activities.
Despite the impact on people’s lives, treatments for hand osteoarthritis are limited and often not effective. However, our recent study has revealed that an existing and affordable medication has the potential to improve pain in patients with hand osteoarthritis, offering hope for relief.
It has been a challenge to find effective treatments for hand osteoarthritis because of the lack of understanding of its underlying causes.
Many doctors believe that osteoarthritis is caused by natural “wear and tear” due to aging, and they do not consider inflammation as a significant factor in hand osteoarthritis.
However, recent research has shown that this belief is incorrect. People with painful hand osteoarthritis often have inflammation, which can lead to joint damage.
Pharmaceutical companies have conducted studies to determine if their new medications, which have been successful in treating other inflammatory joint diseases such as rheumatoid arthritis, can also be effective for patients with hand osteoarthritis.
While biologic disease-modifying anti-rheumatic drugs are not effective in treating hand osteoarthritis, we believe there is potential for other treatments to be explored.
These medications are designed to target a single chemical in the body that causes inflammation, and we hypothesize that a medication with a wider mechanism of action could prove more effective in interrupting the underlying processes causing inflammation.
Experts are currently investigating whether methotrexate, a medication that has been used to treat rheumatoid arthritis successfully for decades, could also be a viable option for hand osteoarthritis.
Methotrexate has a demonstrated record of being safe and effective, and further research into its potential benefits for hand osteoarthritis is expected to yield promising results.
According to experts, methotrexate is a relatively inexpensive treatment option for hand osteoarthritis, costing approximately $100 per year.
This makes it a more accessible option for many patients compared to other treatments, such as biologic disease-modifying anti-rheumatic drugs, which can cost more than $10,000 per year.
Before the study, rheumatologists were surveyed, and it was found that many of them were already prescribing methotrexate “off-label” to treat hand osteoarthritis due to the lack of alternative options available.
